NorthCrest Asset Manangement LLC Purchases 2,967 Shares of Axon Enterprise, Inc $AXON

NorthCrest Asset Manangement LLC lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 947.9% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 3,280 shares of the biotechnology company’s stock after purchasing an additional 2,967 shares during the quarter. NorthCrest Asset Manangement LLC’s holdings in Axon Enterprise were worth $1,939,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of AXON. Norges Bank bought a new position in Axon Enterprise during the second quarter valued at approximately $637,806,000. Vanguard Group Inc. boosted its stake in shares of Axon Enterprise by 4.2% in the 3rd quarter. Vanguard Group Inc. now owns 9,314,164 shares of the biotechnology company’s stock valued at $6,684,217,000 after purchasing an additional 376,904 shares in the last quarter. Jennison Associates LLC grew its holdings in shares of Axon Enterprise by 53.8% during the 3rd quarter. Jennison Associates LLC now owns 943,944 shares of the biotechnology company’s stock valued at $677,412,000 after purchasing an additional 330,213 shares during the last quarter. 1832 Asset Management L.P. grew its holdings in shares of Axon Enterprise by 129.2% during the 2nd quarter. 1832 Asset Management L.P. now owns 536,420 shares of the biotechnology company’s stock valued at $444,124,000 after purchasing an additional 302,420 shares during the last quarter. Finally, Winslow Capital Management LLC raised its position in Axon Enterprise by 43.2% in the 2nd quarter. Winslow Capital Management LLC now owns 375,580 shares of the biotechnology company’s stock worth $310,958,000 after purchasing an additional 113,326 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Market action: AXON closed higher in the most recent session, reflecting short‑term buying interest. Axon Enterprise (AXON) Surpasses Market Returns
• Positive Sentiment: Contract extension: Batavia extended a contract for police body‑camera data storage — a direct revenue/support win for Axon’s cloud evidence/storage business. This reinforces recurring‑revenue visibility from municipal customers. Batavia City Council OKs contract extension for police body camera data storage
• Positive Sentiment: Defense spending narrative: A commentary piece highlights Axon as a top defense/ public‑safety pick amid a large federal spending push, supporting the thesis that defense/first‑responder budgets could be a multi‑year growth tailwind. Hegseth Says It ‘Takes Money to Kill Bad Guys’…
• Positive Sentiment: New local adoption: Syracuse selected Axon as its license‑plate‑reader provider — another municipal win that supports product adoption across public‑safety portfolios. What to know about Axon, Syracuse’s newest license plate reader provider
• Positive Sentiment: Analyst/investor praise: Several investing write‑ups (including The Motley Fool and InsiderMonkeys summaries) continue to highlight Axon’s AI + hardware + subscription model as a high‑growth thesis. These narratives can support multiple expansion if execution stays strong. 2 Tech Stocks That Could Help Make You a Fortune
• Positive Sentiment: Institutional interest note: A recent investor letter/profile highlights Axon as an attractive mid‑cap growth opportunity, signaling continued institutional attention. What Makes Axon (AXON) an Attractive Opportunity?
• Neutral Sentiment: Comparative coverage: A sector comparison piece contrasts Axon with CAE; useful for valuation context but not an immediate catalyst. Contrasting Axon Enterprise and CAE
• Neutral Sentiment: Name confusion alert: AppLovin is expanding a product called “Axon AI” — this is unrelated to Axon Enterprise but can cause headlines/keyword noise; not a company catalyst. AppLovin Expands Axon AI As Investors Weigh Broader Growth Potential
• Neutral Sentiment: Short‑interest data shown for March is effectively blank/inconclusive (reported zeros); no reliable signal on bearish positioning from that data point.
• Negative Sentiment: Insider sale: A director sold ~$77k of stock — a small, single‑sale that could raise mild governance questions but is not large enough alone to indicate a change in company fundamentals. Insider Selling: Axon Enterprise Director Sells Stock
• Negative Sentiment: Local scrutiny: Opinion pieces and calls for mayoral discussion (e.g., Denver) underscore continuing political/community scrutiny over Axon contracts — a recurring risk for municipal renewals and reputation. Mike Johnston Says He’s Listening, but Will He Meet With Constituents?

Analyst Ratings Changes

AXON has been the subject of several recent research reports. Barclays lowered their price target on shares of Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Royal Bank Of Canada decreased their price objective on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 target price for the company in a research note on Tuesday, January 6th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a report on Saturday, February 28th. Finally, UBS Group decreased their price target on Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 25th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $762.93.

Axon Enterprise Price Performance

AXON stock opened at $507.28 on Tuesday. The stock has a market capitalization of $40.79 billion, a price-to-earnings ratio of 333.74, a PEG ratio of 10.59 and a beta of 1.46. The firm’s 50-day moving average price is $516.98 and its two-hundred day moving average price is $597.88. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 12-month low of $396.41 and a 12-month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The company had revenue of $796.72 million during the quarter, compared to analyst estimates of $755.29 million. During the same period in the prior year, the business posted $2.08 earnings per share. Axon Enterprise’s revenue for the quarter was up 38.5% on a year-over-year basis. As a group, equities analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Erika Nardini sold 198 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the sale, the director owned 1,946 shares of the company’s stock, valued at $985,804.68. This trade represents a 9.24% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Jeri Williams sold 157 shares of Axon Enterprise stock in a transaction on Tuesday, March 17th. The shares were sold at an average price of $490.00, for a total transaction of $76,930.00. Following the completion of the sale, the director owned 1,159 shares in the company, valued at approximately $567,910. This trade represents a 11.93% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 23,855 shares of company stock worth $13,299,928. Insiders own 5.70% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.